Page last updated: 2024-10-24

celecoxib and Fibrous Dysplasia of Bone

celecoxib has been researched along with Fibrous Dysplasia of Bone in 1 studies

Fibrous Dysplasia of Bone: A disease of bone marked by thinning of the cortex by fibrous tissue containing bony spicules, producing pain, disability, and gradually increasing deformity. Only one bone may be involved (FIBROUS DYSPLASIA, MONOSTOTIC) or several (FIBROUS DYSPLASIA, POLYOSTOTIC).

Research Excerpts

ExcerptRelevanceReference
"Celecoxib is a cyclooxygenase-2 (COX2) inhibitor."1.46Celecoxib treatment of fibrous dysplasia (FD) in a human FD cell line and FD-like lesions in mice with protein kinase A (PKA) defects. ( Bhattacharyya, N; Collins, M; Leikin, S; Liu, S; Mertz, EL; Nesterova, M; Saloustros, E; Salpea, P; Starost, MF; Stratakis, CA, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Saloustros, E1
Liu, S1
Mertz, EL1
Bhattacharyya, N1
Starost, MF1
Salpea, P1
Nesterova, M1
Collins, M1
Leikin, S1
Stratakis, CA1

Other Studies

1 other study available for celecoxib and Fibrous Dysplasia of Bone

ArticleYear
Celecoxib treatment of fibrous dysplasia (FD) in a human FD cell line and FD-like lesions in mice with protein kinase A (PKA) defects.
    Molecular and cellular endocrinology, 2017, 01-05, Volume: 439

    Topics: Animals; Apoptosis; Bone and Bones; Celecoxib; Cell Line; Cell Proliferation; Cyclic AMP-Dependent P

2017